# Endocardial Stem Cells Approach Efficacy

> **NCT00841958** · PHASE3 · COMPLETED · sponsor: **Meshalkin Research Institute of Pathology of Circulation** · enrollment: 250 (actual)

## Conditions studied

- Myocardial Ischemia

## Interventions

- **PROCEDURE:** Autologous bone marrow mononuclear stem cells or peripheral blood stem cells

## Key facts

- **NCT ID:** NCT00841958
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2012-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00841958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00841958, "Endocardial Stem Cells Approach Efficacy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00841958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*